Keynote remarks and conversation
Today, 43 million Americans have prescription drug coverage through Medicare Part D, roughly double the number since the program’s introduction in 2006. In the wake of fast-growing drug prices and the rise of specialty drugs, renewed attention has focused on reforming Part D’s benefit structure and providing plans with more tools to obtain lower drug prices. The Trump administration has issued a series of recommendations in their “Blueprint to Lower Drug Prices” and the president’s budget, and the administration has already begun to advance several pricing reforms through regulation.
On October 18, the USC-Brookings Schaeffer Initiative for Health Policy hosted Seema Verma, the administrator of the Centers for Medicare and Medicaid Services, for a discussion about Medicare Part D and what can be done to improve the program. Following her presentation, Ms. Verma sat down with USC Schaeffer Center for Health Policy & Economics Director Dana Goldman for an interview. A panel of experts then discussed the administrator’s comments and related issues in the Medicare Part D program.
Judge Robert Maclay Widney Chair and Professor - USC Schaeffer Center for Health Policy & Economics and USC Price School of Public Policy
Trustee - University of Southern California
Trustee - Brookings Institution
Leonard D. Schaeffer Director's Chair - Schaeffer Center for Health Policy & Economics
Distinguished Professor of Public Policy, Pharmacy, & Economics - Sol Price School of Public Policy and USC School of Pharmacy
Nonresident Senior Fellow - Economic Studies, Center for Health Policy
Former Chief Medical Officer - Anthem, Inc.
Quintiles Senior Fellow - USC Schaeffer Center
Clinical Professor - Washington University School of Medicine
Strategic Advisor - Epstein Becker Green
Associate Professor, Health Policy, Ingram Associate Professor of Cancer Research - Vanderbilt University Medical Center
Director of Health Policy - USC Schaeffer Center for Health Policy & Economics, University of Southern California
Chair of Pharmaceutical and Health Economics Department - USC School of Pharmacy
Associate Professor, Pharmaceutical Economics and Policy - USC School of Pharmacy
To subscribe or manage your subscriptions to our top event topic lists, please visit our event topics page.